On Thursday shares of CEL-SCI Corporation (NYSEMKT:CVM) closed at $0.89. Company’s sales growth for last 5 years was 24.60%. On 14 April, CEL-SCI Corporation (NYSEMKT:CVM) announced that Aintree University Hospital, in Liverpool, England, has become a clinical site for the Company’s global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). This is the first center to join the Multikine Phase III study in the UK.
Verastem, Inc. (NASDAQ:VSTM) in last trading activity increased 0.50% to close at $10.04. Company weekly performance is 0.50% while its quarterly performance stands at 43.43%. Verastem, Inc. (NASDAQ:VSTM) is -18.70% away from its 52 week high. On 22 April, Verastem, Inc. (NASDAQ:VSTM) announced the presentation of scientific data at the 2015 American Association of Cancer Research (AACR) Annual Meeting. The data presented provide continued evidence that VS-6063, VS-4718 and VS-5584 effectively target cancer stem cells, reduce tumor initiating capability and prolong the anti-tumor response to standard of care chemotherapy in preclinical models of multiple tumor types.
On last trading day Werner Enterprises Inc. (NASDAQ:WERN) fell -0.10% to close at $30.26. Its volatility for the week is 2.86% while volatility for the month is 2.43%. WERN’s sales growth for past 5 years was 5.10% and its EPS growth for past 5 years was 11.50%. Werner Enterprises Inc. (NASDAQ:WERN) monthly performance is -5.93%. On 15 April, Enterprises Inc. (NASDAQ:WERN) said that, it was recognized by Military Times with a spot on its Best for Vets: Employers 2015 Rankings. This is the second time Werner has been named to the list, which is based on a nearly 90-question analysis of a company’s efforts to connect with veterans and provide an environment for success.
TIM Participacoes S.A. (NYSE:TSU) has institutional ownership stands at 15.80%. In last trading activity company’s stock closed at $16.75. Citigroup Inc. upgraded shares of TIM Participacoes S.A. (NYSE:TSU) from a sell rating to a neutral rating in a report issued on Thursday.
On last trading day Symantec Corporation (NASDAQ:SYMC) increased 1.15% to close at $24.64. Its volatility for the week is 2.58% while volatility for the month is 2.57%. SYMC’s sales growth for past 5 years was 1.70% and its EPS growth for past 5 years was 16.60%. Symantec Corporation (NASDAQ:SYMC) monthly performance is 2.16%.On 17 April, Symantec Corporation (NASDAQ:SYMC) said that, it is moving ahead with its plans to split into two publicly traded companies by January, a move that it views as more tax-efficient than a sale of one of its units.